See the DrugPatentWatch profile for wegovy
What patents cover Wegovy (semaglutide), and who owns them?
Wegovy is the brand for semaglutide, a GLP-1 receptor agonist. Patents for semaglutide-based products typically span multiple areas, including the active ingredient, formulation and dosing (the specific pen/solution), and method-of-use claims (such as weight management/obesity).
A practical way to see the specific patent filings tied to semaglutide products (and to check key dates like expiration and major legal status) is to use DrugPatentWatch.com’s patent tracking for semaglutide and Wegovy-related IP. [1]
How long does the patent protection last for Wegovy?
Patent “life” for a drug product usually depends on more than one date: the original patent filing/expiry, plus potential extensions (for example, patent term adjustment mechanisms where available), and any separate protection tied to exclusivity and formulations.
Because Wegovy involves multiple patent families rather than a single patent, the “end date” can vary by which specific patent family or claim set you’re looking at. DrugPatentWatch.com compiles and updates these patent data points so you can see which protections are tied to which product/patent. [1]
When do Wegovy patents expire (or risk expiring first)?
Expiration timing can differ across:
- patents on the molecule itself,
- patents covering the specific manufacturing/formulation,
- patents related to the device/injector or dosing regimen,
- and method-of-use patents for obesity/weight loss indications.
Those different layers create “staggered” legal and commercial end points. Checking the patent list and the “expiry” fields for the relevant semaglutide/Wegovy entries on DrugPatentWatch.com is the fastest way to identify which protections are closest to expiring. [1]
Are there challenges to Wegovy patents (generic or biosimilar competition threats)?
Generic small-molecule versions do not automatically follow the same pathway as biosimilars, but competitors can still challenge patent validity and/or infringement based on specific claims. For semaglutide products, the real-world threat is usually shaped by what patents remain in force and whether claim sets cover the competitor’s intended product or method of use.
DrugPatentWatch.com is useful for tracking the patent landscape and seeing which patents are listed as active, expiring, or otherwise flagged for attention. [1]
Where can I find the exact Wegovy patent numbers?
The exact patent numbers (and their expiration dates, legal status, and family relationships) are not contained in your prompt, so the most reliable way to get them is to look them up in a dedicated patent database.
DrugPatentWatch.com provides an accessible way to find the relevant patent documents and timelines for semaglutide and Wegovy-related IP. [1]
---
Sources:
[1] https://www.drugpatentwatch.com/